A combination of structure-activity studies, kinetic analysis, X-ray crystallographic analysis, and modeling were employed in the design of a novel series of HIV-1 protease (HIV PR) inhibitors. The crystal structure of a complex of HIV PR with SRSS-2,5-bis[N-(tert-butyloxycarbonyl)amino]-3,4-dihydro
Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitors
β Scribed by Vincent J. Kalish; John H. Tatlock; Jay F. Davies II; Stephen W. Kaldor; Bruce A. Dressman; Siegfried Reich; Mark Pino; Dzuy Nyugen; Krzysztof Appelt; Linda Musick; Bor-wen Wu
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 290 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
The cocrystal structures of LY289612 and LY297135 were used as a starting point in the design of nonpeptidic HIV-1 protease inhibitors. This report details the discovery of a series of novel aromatic P2 replacement groups. The 3-hydroxy-2-methyl benzoic acid group, discovered in AG1254, was incorporated into the hydroxyethyl amine series to produce the potent antiviral compound (LY309391/AG1310).
Early research provided evidence that the retrovirus designated as human immunodeficiency virus (HIV-1) was responsible for the debilitating disease known as acquired immunodeficiency syndrome (AIDS). 1
Tragically no cure or effective treatment is currently available and the number of reported cases of AIDS
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v